MedTrace Logo

Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures

NCT03859635 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-02-28

Study results available
· View outcomes & findings →

Summary

The study is comparing the difference between erector spinae block and surgeon infiltration after VATS (Video Assisted Thoracoscopic Surgery). The outcomes measured are pain scores, opioid usage, opioid side effects, and patient satisfaction.We are also also studying the effectiveness of liposomal bupivacaine (EXPAREL) in a block by randomizing patients to both EXPAREL erector spinae block and simple bupivacaine erector spinae block.

Conditions

  • Pain, Postoperative
  • Thoracic
  • Acute Pain

Interventions

DRUG

Liposomal Bupivacaine

20 ml

DRUG

Bupivacaine, 0.25%

10 ml

DRUG

Bupivacaine, 0.5%

30 ml

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Yar Yeap, MD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-07
Primary Completion
2022-11-06
Completion
2022-11-07
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03859635 on ClinicalTrials.gov